Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seder Capital is an investment management firm that focuses on the healthcare and life sciences sectors. The company provides capital and strategic support to emerging biotechnology and medical technology companies, aiming to accelerate the development of innovative therapies and healthcare solutions. Seder Capital leverages its deep industry expertise to identify high-potential investment opportunities across various therapeutic areas. By partnering with visionary entrepreneurs, the firm seeks to drive value creation and improve patient outcomes through the advancement of cutting-edge medical science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seder Capital.